PRC1 and alveolar rhabdomyosarcoma: Thus, we hypothesized that a member of PRC1, B lymphoma Mo‐MLV insertion region 1 (BMI1), also known as polycomb group factor 4 (PCGF4), would be a viable epigenetic target in ARMS.